Is it Time to Start Using Mitochondrial DNA Copy Number as an Indicator of Health and Diseases?

Abstract

Clinical biochemistry and pathology have contributed too many assays for diagnosis
and prognosis of human health and diseases. Bedside biochemistry has revolutionized modern
medicine and the invention of new generation biosensors have educated the patients like never
before. Although, there are many gadgets which are available for monitoring the blood glucose
in the patients with metabolic syndromes, hardly any assays can accurately predict and aid
in early detection of metabolic syndrome. By the time a person is diagnosed and treated for
metabolic syndrome, molecular and pathological damages further push the patient towards the
metabolic syndrome. Early detection and early treatments are necessary to further revolutionize
the field of Medicine.